Results 31 to 40 of about 3,513,300 (309)

Adverse Effects of Ligation of an Aberrant Left Hepatic Artery Arising from the Left Gastric Artery during Radical Gastrectomy for Gastric Cancer: a Propensity Score Matching Analysis [PDF]

open access: yes, 2021
Purpose: No consensus exists on whether to preserve or ligate an aberrant left hepatic artery (ALHA), which is the most commonly encountered hepatic arterial variation during gastric surgery.
손태일   +7 more
core   +1 more source

Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center

open access: yesBMC Cancer, 2018
Background Greater lymph node retrieval in gastric cancer improves staging accuracy and may improve survival from increased clearance of nodal micrometastasis.
Shiela S. Macalindong   +10 more
doaj   +1 more source

The impact of hiatal hernia on survival outcomes in patients with gastroesophageal junction adenocarcinoma

open access: yesAnnals of Gastroenterological Surgery, 2022
Aim A hiatal hernia (HH) complicates the diagnosis and surgical treatment of gastroesophageal junction (GEJ) cancer. This study aimed to investigate the effect of HH on the survival outcomes of GEJ cancer patients.
Yuya Tanaka   +7 more
doaj   +1 more source

Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells

open access: yesMedComm, 2023
Drug resistance remains the greatest challenge in improving outcomes for cancer patients who receive chemotherapy and targeted therapy. Surmounting evidence suggests that a subpopulation of cancer cells could escape intense selective drug treatment by ...
Xiaohai Song   +13 more
doaj   +1 more source

Clinical Outcomes of Endoscopic Hemostasis for Bleeding in Patients with Unresectable Advanced Gastric Cancer [PDF]

open access: yes, 2017
Purpose: Bleeding is one of the most serious complications of advanced gastric cancer (AGC) and is associated with a poor prognosis. This study aimed to evaluate the clinical outcomes of endoscopic hemostasis for bleeding in patients with unresectable ...
정현수   +6 more
core   +1 more source

Is the Reinitiation of Antiplatelet Agents Safe at 1 Week after Gastric Endoscopic Submucosal Dissection? Assessment of Bleeding Risk Using the Forrest Classification

open access: yesGut and Liver, 2017
Background/AimsDelayed bleeding after gastric endoscopic submucosal dissection (ESD) commonly occurs within 3 days, but it may also occur after 1 week following ESD, especially in antiplatelet agent users.
Jong Yeul Lee   +4 more
doaj   +1 more source

Recurrence after ESD curative resection for early gastric cancer

open access: yesSurgical Case Reports, 2021
Background Endoscopic submucosal dissection (ESD) is gaining ground as a minimally invasive treatment for early gastric cancer (EGC) that has a negligible risk of lymph node metastasis.
Ayako Kamiya   +12 more
doaj   +1 more source

Gastric Microbiome and Gastric Cancer [PDF]

open access: yesThe Cancer Journal, 2014
Cancer of the stomach is the fourth most common cancer worldwide. The single strongest risk factor for gastric cancer is Helicobacter pylori-associated chronic gastric inflammation. Among persons with H. pylori infection, strain-specific components, host immune responses, and environmental factors influence the risk for gastric disease, including ...
Kyle M, Brawner   +2 more
openaire   +2 more sources

Association between Chemotherapy-Response Assays and Subsets of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Pilot Study [PDF]

open access: yes, 2015
PURPOSE: The purpose of this pilot study was to evaluate the association between adenosine triphosphate-based chemotherapy response assays (ATP-CRAs) and subsets of tumor infiltrating lymphocytes (TILs) in gastric cancer. MATERIALS AND METHODS: In total,
김충배   +6 more
core   +1 more source

The role of gastric microbiota in gastric cancer [PDF]

open access: yesGut Microbes, 2020
Gastric cancer represents one of the leading causes of cancer deaths worldwide. Helicobacter pylori (H. pylori) infection is the strongest risk factor associated with gastric cancer. Due to new molecular techniques allowing greater identification of stomach microbes, investigators are beginning to examine the role that bacteria other than H.
Oliver A. Stewart, Fen Wu, Yu Chen
openaire   +3 more sources

Home - About - Disclaimer - Privacy